KMPHARMACEUTICAL: Paid-in Capital Increase
케이엠제약
225430
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2547
Risk-adjusted indicator based on 2547 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Discount Rate: 10%
- • Lock-up Period: 1 year for new shares
AI Analysis Summary
KMPHARMACEUTICAL Co.,Ltd. has decided on a paid-in capital increase via a third-party allocation. The new shares will be issued at a 10% discount to the reference price, calculated based on weighted average stock prices. All new shares will be subject to a 1-year lock-up period, restricting withdrawal and sale. The specific number of shares, issuance price, and funding purpose (e.g., facility, operations, debt repayment) are not yet disclosed in this report, limiting a full assessment of dilution and financial impact. Further details are required for a comprehensive analysis.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.